TY - JOUR
T1 - The Association of Predicted Resting Energy Expenditure with Risk of Breast Cancer among Postmenopausal Women in the Women's Health Initiative Cohort
AU - Arthur, Rhonda S.
AU - Mossavar-Rahmani, Yasmin
AU - Prentice, Ross L.
AU - Shadyab, Aladdin H.
AU - Luo, Juhua
AU - Sattari, Maryam
AU - Xue, Xiaonan
AU - Kamensky, Victor
AU - Chen, Guo Chong
AU - Qi, Qibin
AU - Anderson, Garnet L.
AU - Wassertheil-Smoller, Sylvia
AU - Neuhouser, Marian L.
AU - Rohan, Thomas E.
N1 - Funding Information:
Y. Mossavar-Rahmani reports grants from NIH during the conduct of the study. R.L. Prentice reports grants from NIH during the conduct of the study. Q. Qi reports grants from NIH outside the submitted work. G.L. Anderson reports grants from National Heart, Lung, and Blood Institute (NHLBI) during the conduct of the study. S. Wassertheil-Smoller reports grants from NIH during the conduct of the study. No disclosures were reported by the other authors.
Funding Information:
T.E. Rohan is supported by the Breast Cancer Research Foundation (BCRF-16–140). We thank the WHI investigators, staff, and the trial participants for their outstanding dedication and commitment. WHI investigators: Program Office: (National Heart, Lung, and Blood Institute, Bethesda, MD) Jacques Roscoe, Shari Ludlum, Dale Burden, Joan McGowan, Leslie Ford, and Nancy Geller.
Publisher Copyright:
© 2022 American Association for Cancer Research Inc.. All rights reserved.
PY - 2022/4
Y1 - 2022/4
N2 - Obesity and obesity-related metabolic disorders, such as diabetes and chronic inflammation, have been positively associated both with postmenopausal breast cancer and with resting energy expenditure (REE). However, there is limited epidemiologic evidence on the associations between REE and risk of postmenopausal breast cancer. We used multivariable Cox proportional hazards models to examine the association between predicted REE (calculated using the Ikeda, Livingston, and Mifflin equations) and risk of postmenopausal breast cancer overall and by subtypes, and by level of body fat) among 137,283 postmenopausal women in the Women's Health Initiative (WHI). All predicted REEs were positively associated with risk of invasive breast cancer [HRq5 vs. q1 = 1.69; 95% confidence interval (CI), 1.57-1.81; HR = 1.69; 95% CI, 1.57-1.82; and HR = 1.68; 95% CI, 1.56-1.80 for Ikeda, Livingston, and Mifflin, respectively]. These positive associations were observed irrespective of the hormone receptor subtype, grade, and stage of the tumors, but were most pronounced for estrogen receptor-positive/progesterone receptor-positive tumors. After additional adjustment for body mass index (BMI), the associations were mostly attenuated and remained statistically significant for most of the outcomes. We also observed an interaction between the predicted REEs and BMI, with the associations being somewhat stronger among normal weight and overweight women than among obese women (Pinteractions < 0.05). Our findings indicate that relatively high REE is associated with increased risk of invasive breast cancer among postmenopausal women (particularly for the obesity-related tumor subtypes), irrespective of the equation used. Further studies using more objective measures of REE are, however, needed to confirm our findings.
AB - Obesity and obesity-related metabolic disorders, such as diabetes and chronic inflammation, have been positively associated both with postmenopausal breast cancer and with resting energy expenditure (REE). However, there is limited epidemiologic evidence on the associations between REE and risk of postmenopausal breast cancer. We used multivariable Cox proportional hazards models to examine the association between predicted REE (calculated using the Ikeda, Livingston, and Mifflin equations) and risk of postmenopausal breast cancer overall and by subtypes, and by level of body fat) among 137,283 postmenopausal women in the Women's Health Initiative (WHI). All predicted REEs were positively associated with risk of invasive breast cancer [HRq5 vs. q1 = 1.69; 95% confidence interval (CI), 1.57-1.81; HR = 1.69; 95% CI, 1.57-1.82; and HR = 1.68; 95% CI, 1.56-1.80 for Ikeda, Livingston, and Mifflin, respectively]. These positive associations were observed irrespective of the hormone receptor subtype, grade, and stage of the tumors, but were most pronounced for estrogen receptor-positive/progesterone receptor-positive tumors. After additional adjustment for body mass index (BMI), the associations were mostly attenuated and remained statistically significant for most of the outcomes. We also observed an interaction between the predicted REEs and BMI, with the associations being somewhat stronger among normal weight and overweight women than among obese women (Pinteractions < 0.05). Our findings indicate that relatively high REE is associated with increased risk of invasive breast cancer among postmenopausal women (particularly for the obesity-related tumor subtypes), irrespective of the equation used. Further studies using more objective measures of REE are, however, needed to confirm our findings.
UR - http://www.scopus.com/inward/record.url?scp=85128160965&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128160965&partnerID=8YFLogxK
U2 - 10.1158/1940-6207.CAPR-21-0467
DO - 10.1158/1940-6207.CAPR-21-0467
M3 - Article
C2 - 35012972
AN - SCOPUS:85128160965
SN - 1940-6207
VL - 15
SP - 255
EP - 264
JO - Cancer Prevention Research
JF - Cancer Prevention Research
IS - 4
ER -